Principles and Practice of Cancer Infectious Diseases

Infections in Patients with Cancer – An Overview.- Infections in Patients Undergoing Hematopoietic Stem Cell Transplantation.- Infections in Patients with Hematologic Malignancy.- Infections in Patients with Solid-Organ Cancer.- Infections in Patients Treated with Monoclonal Antineoplastic Therapy.- Infections in Cancer Patients Undergoing Surgical Procedure.- Infections in Critically Ill Cancer Patients.- Management of Neutropenic Patients with Fever.- Controversies in Empiric Therapy for Febrile Neutropenia.- Catheter-Related Bloodstream Infections.- Treatment Strategies for Infected Indwelling Intravascular Devices.- Pneumonia and Other Lung Infections.- Noninfectious Lung Infiltrates Difficult to Distinguish from Pneumonia.- Orointestinal Mucosal Barrier Injury and Risk of Infection.- Intestinal Tract Bacterial Colonization and Host’s Innate Immunity.- Neutropenic Enterocolitis and Clostridium difficile Associated Diarrhea.- Management of Hepatitis B and C Virus Reactivation in Cancer Patients.- Infections in Patients with Genitourinary Tract Cancer.- Central Nervous System Infections in Patients with Cancer.- Endocarditis in Cancer Patients – Endovascular Infections and Noninfectious Paraneoplastic Diseases.- Skin Infections and Disorders Confused with Infections in Cancer Patients.- Overview of Fungal Infections.- Diagnosis of Invasive Fungal Disease in Cancer Patients.- Invasive Candidiasis and Candidemia in Cancer Patients.- Management of Aspergillosis, Zygomycosis, and Other Clinically Relevant Mold Infections in Patient with Cancer.- Endemic Mycosis and Cryptococcal Disease.- Controversies in Management of Invasive Fungal Disease in Cancer Patients.- Fungal Drug Resistance and Pharmacologic Consideration of Dosing New Antifungal Agents.- Immunotherapy for Difficult-to-Treat Invasive Fungal Disease in Patients with Hematologic Malignancy and Stem Cell Transplantation.- Cytomegalovirus in Patients with Cancer.- Epstein-Barr virus, VaricellaZoster virus, and Human Herpes virus 6 & 8 Infections in Cancer Patients.- Respiratory Viruses.- BK, JC and Parvovirus Infections in Patients with Hematologic Malignancy.- Antiviral Drug Resistance and Implications for Prophylaxis for High Risk Cancer Population.- Management of Gram-Positive Bacterial Disease: Stapylococcus aureus, Pneumococcus, Streptococcal and Enterococcal Infections.- Management of Gram-Negative Bacterial Disease in Cancer Patients.- Listeriosis and Nocardiosis in Cancer Population.- Antimicrobial Distribution and Drug-Drug Interaction in Cancer Patients.- Mycobacterium tuberculosis Infection in Cancer Patients.- Nontuberculous Mycobacterial Infections in Cancer Patients.- Parasitic Infections in Cancer Patients: Toxoplasmosis, Strongyloidiasis and Other Parasites.- Zoonoses in Cancer Patients.- Antibiotic Stewardship Considerations for Cancer Centers
Coralia Mihu.- Controversies in Planning and Implementation of Antimicrobial Stewardship Programs.- Prevention of Drug Resistance among Common Healthcare- Associated Pathogens – Current Practice and Future Strategies.- Antibacterial, Antifungal and Antiviral Prophylaxis in High-Risk Cancer and Stem Cell Transplant Population.- Controversies in Antimicrobial Prophylaxis.- Protected Environment and Infection Control.- Travel Medicine – Prevention of Tropical and Parasitic Diseases.- Immunization – Strategies to Improve Vaccine Response in Cancer and Hematopoietic Transplant Population